News
EscharEx® is a bromelain-based, bioactive enzymatic therapy in advanced clinical development ... expectations and commercial potential of our products and product candidates, including EscharEx®.
The presentations will feature new preclinical and clinical data on EscharEx ®, MediWound’s investigational enzymatic therapy for chronic wounds. The findings offer important insights into ...
EscharEx ® is a bromelain-based, bioactive enzymatic therapy in advanced clinical development for ... expectations and commercial potential of our products and product candidates, including EscharEx ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results